Aidoc: The AI Radiology Breakthrough Every Hospital Executive Should Know
What is Aidoc? Aidoc provides an enterprise clinical AI operating system (aiOS™) and a portfolio of medical imaging algorithms that run continuously to triage urgent findings, quantify measurements, and coordinate follow-up across care teams. The platform centrally ingests imaging (and report/EHR metadata), applies multiple validated AI models in parallel, prioritises worklists, notifies clinicians of suspected […]
Feature Categories
What is Aidoc?
Aidoc provides an enterprise clinical AI operating system (aiOS™) and a portfolio of medical imaging algorithms that run continuously to triage urgent findings, quantify measurements, and coordinate follow-up across care teams. The platform centrally ingests imaging (and report/EHR metadata), applies multiple validated AI models in parallel, prioritises worklists, notifies clinicians of suspected acute pathologies (e.g., ICH, LVO, PE, pneumothorax, aortic disease), and routes patients into follow-up workflows and analytics.
Deployments emphasise integration with PACS/EHR/RIS and scale across health systems — enabling both acute-care triage and population-health workflows (e.g., coronary artery calcification capture for preventative cardiology). The company publishes clinical studies and partners with cloud and EHR vendors to accelerate enterprise rollouts.
Why Leading Healthcare Teams Trust Aidoc
- FDA clearance obtained for detecting large-vessel occlusions in head CTA examinations in January 2020
- Received 6th FDA clearance for AI solution detecting incidental pulmonary embolism in May 2024
- Two FDA-approved AI triage programs currently available: BriefCase-IFG for intra-abdominal free gas detection and BriefCase-CT for vertebral compression fractures
- One of the broadest ranges of FDA-cleared and CE/UKCA-marked algorithms in clinical AI
- First company in radiology to receive FDA clearance for AI-based workflow optimization in August 2018
- Market leader in AI radiology space with impressive FDA approval achievement
- Partnership with Radiology Partners represents the largest clinical deployment of AI in healthcare
- Trusted by radiologists from University of Rochester Medical Center and Einstein Healthcare
- Raised $110 million in Series D funding in January 2025
- Series C round of $66 million led by General Catalyst in 2024
- Total funding of $420 million with investors including Amazon Web Services, Hartford HealthCare, and Mercy
- Collaboration with NVIDIA to develop AI deployment framework for healthcare as of October 2024
- Working with major health systems including Sutter Health and NVentures
- First deep learning solution for detecting acute intracranial hemorrhage using AI
- Always-on AI platform providing continuous monitoring and triage capabilities
- Multi-pathology detection across various imaging modalities
Top 3 Pain Points Aidoc Fixes in Healthcare
| Problem | How Aidoc Solves It |
|---|---|
| 1. Delayed detection of acute findings (e.g., stroke, hemorrhage, pulmonary embolism) | Aidoc continuously scans images in real time, flags urgent cases, and notifies care teams — enabling faster diagnosis and treatment. |
| 2. Radiologist workflow overload | By reprioritizing worklists and integrating alerts directly into PACS/EHR, Aidoc helps radiologists manage high volumes efficiently and reduce missed findings. |
| 3. Fragmented care coordination | Aidoc routes actionable results into follow-up workflows, ensures patients receive proper care, and improves communication across teams. |
Feature Category Summary: Aidoc
| Feature Category | Summary | Association (YES, NO, NA) |
|---|---|---|
| Regulatory-Ready | Aidoc offers FDA 510(k)-cleared AI solutions across multiple imaging indications and states that its products hold multiple global clearances including US FDA, EU MDR/CE, Australian TGA, and certification under MDSAP and ISO 13485, with quality systems aligned to FDA Quality System Regulation; FAQs also emphasize adherence to strict global security and privacy standards, though detailed GxP manufacturing documentation and audit-trail specifications are not publicly described. | YES |
| Clinical Trial Support | Available documentation presents Aidoc as an enterprise clinical AI platform deployed in live clinical environments and supported by numerous validation and ROI studies of its own algorithms, but there is no explicit evidence that the platform provides dedicated modules for clinical trial design, patient recruitment, monitoring, or reporting for external investigational products. | NA |
| Supply Chain & Quality | No public documentation found indicating that Aidoc provides features for pharmaceutical or device supply-chain tracking, counterfeit detection, manufacturing integrity monitoring, or GMP/GQP quality-release workflows; its focus is on clinical imaging AI and workflow orchestration in provider settings. | NA |
| Efficiency & Cost-Saving | Aidoc describes its always-on aiOS platform as automating case prioritization, triage, and care-team activation across emergency, inpatient, and outpatient workflows, with customer evidence of reduced turnaround times, faster time-to-diagnosis, and operational and financial improvements for health systems. | YES |
| Scalable / Enterprise-Grade | The aiOS platform is marketed as an enterprise clinical AI operating system deployed in more than a thousand hospitals worldwide, designed for health-system-wide rollout with centralized orchestration, remote deployment, and adherence to SOC 2 and other security standards, demonstrating scalability for large healthcare enterprises (though not specifically for pharma/biotech environments). | YES |
| HIPAA Compliant | Aidoc’s FAQ explicitly states that its solutions are HIPAA and GDPR compliant, noting that AI processing is performed on de-identified studies and that no patient health information leaves the customer facility, and other materials describe the platform as HIPAA-compliant with de-identification built into the single enterprise platform. | YES |
| Clinically Validated | Press releases, FDA summaries, and marketing materials report multiple clinical validation and performance studies for Aidoc’s algorithms, with more than 200 validation and ROI studies cited across various modalities and pathologies, supporting evidence of clinical validation for the intended imaging triage and notification uses. | YES |
| EHR Integration | Aidoc describes its systems-integration capabilities as connecting to PACS, RIS, EHR, and other hospital systems via standards such as DICOM, HL7, and FHIR, and specific materials highlight an EHR integration layer that can work with any EHR and is available through major EHR app marketplaces to bring imaging AI outputs and clinical context directly into clinician workflows. | YES |
| Explainable AI | Public product descriptions focus on automation, triage, and workflow alerts, and while Aidoc’s educational content discusses transparency and understanding AI outputs in general terms, there is no explicit evidence of productized explainability features such as dedicated explanation panels, per-case feature attributions, or visual saliency explanations being systematically provided to end users. | NA |
| Real-Time Analytics | Aidoc characterizes its platform as always-on AI that processes imaging studies as they are acquired, issuing real-time flags, notifications, and activations to care teams across the hospital, and emphasizes 24/7 automated monitoring and rapid triage as core capabilities. | YES |
| Bias Detection | Aidoc publishes guidance on bias in healthcare AI and outlines questions providers should ask about nondiscrimination and fairness, and blog content explains how Aidoc approaches bias risk, but there is no explicit description of an in-product bias-detection or reporting module that quantifies performance across demographic or clinical sub-cohorts. | NA |
| Ethical Safeguards | Company blogs and thought-leadership pieces discuss AI governance, legal and ethical implications, regulation–governance handshakes, and the importance of human oversight and privacy-by-design, yet public documentation does not detail concrete built-in governance controls such as configurable consent workflows, hard human-in-the-loop enforcement, or technical use-case restriction mechanisms within the platform. | NA |
Risks & Limitations: Aidoc
-
Alert fatigue / low PPV at high sensitivity: aggressive thresholds can overwhelm clinicians—site-level tuning and workflow design needed.
-
Generalisability & scanner variability: image quality and protocol heterogeneity affect performance; initial calibration and QA are essential.
-
Workflow dependence: AI only shortens time-to-action if clinical escalation pathways and staffing exist to respond to alerts.
-
Regulatory/market nuance: module availability and regulatory clearance vary by market—confirm intended-use statements for each module before procurement.
Share This AI Tool
